Deferred Tax Assets, Valuation Allowance of Protagonist Therapeutics, Inc from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Protagonist Therapeutics, Inc quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Protagonist Therapeutics, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $167,141,000, a 45% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Protagonist Therapeutics, Inc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $167,141,000 +$51,736,000 +45% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q4 2024 $115,405,000 -$50,860,000 -31% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q4 2023 $166,265,000 +$28,127,000 +20% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q4 2022 $138,138,000 +$34,230,000 +33% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q4 2021 $103,908,000 +$31,999,000 +44% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q4 2020 $71,909,000 +$19,378,000 +37% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q4 2019 $52,531,000 +$18,491,000 +54% 31 Dec 2019 10-K 10 Mar 2021 2020 FY
Q4 2018 $34,040,000 +$8,153,000 +31% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q4 2017 $25,887,000 +$1,916,000 +8% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q4 2016 $23,971,000 +$13,400,000 +127% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q4 2015 $10,571,000 31 Dec 2015 10-K 07 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.